← Leaderboards
Juraj Koska
Arizona Veterans Research And Education Foundation
$111,647
Attributed
$223,294
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $117.1K · FY2019–20$200K$150K$100K$50K$0
'19
'20
Funding mix
By agency
NIH$223,294 · 1
By mechanism
R21$223,294 · 1
Top collaborators
- Peter D Reaven2 shared
Others in their field
Other Emerging Leaders on “Atherosclerosis”
- Bing Yu · University Of Tx Md Anderson Can Ctr$10,701,288
- Badri N Vardarajan · University Of Miami School Of Medicine$10,244,025
- Pradeep Natarajan · Massachusetts General Hospital$9,255,801
- Jose Gutierrez · Columbia University Health Sciences$7,601,653
- Stephen P Juraschek · Beth Israel Deaconess Medical Center$6,842,455
- William Raymond Lagor · Baylor College Of Medicine$6,500,004
Research focus
AtherosclerosisBloodBlood VesselsCardiovascular DiseasesCardiovascular Disorder RiskCardiovascular Risk FactorCardiovascular SystemCarotid Atherosclerotic DiseaseCase ControlClinical ResearchCohortComplications Of Diabetes MellitusCoronaryCoronary ArteriosclerosisDiabetes MellitusDiscriminationEpidemiology StudyEvaluationEventFutureGlomerular Filtration RateGlucoseGlycemic ControlAdvanced Glycosylation End Products
Grant awards (2)
Role of Methionine Sulfoxide and Advanced Glycation Endproducts in Cardiovascular and Renal Complications of Type 2 Diabetes$106,147
R21 · FY2020 · HL · contact PI
Role of Methionine Sulfoxide and Advanced Glycation Endproducts in Cardiovascular and Renal Complications of Type 2 Diabetes$117,147
R21 · FY2019 · HL · contact PI